SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: robert miller who wrote (4353)7/26/2001 9:27:04 AM
From: Biomaven  Respond to of 52153
 
That's certainly good news for KOSP. The FDA in general hates fixed combination drugs and makes approval quite difficult.

Still no news on what's happening with the BMY merger as it relates to this drug. I continue to believe that we will see something quite favorable happen as a result of the merger.

Peter